EGFR Positive Lung Cancer UK
EGFR Positive UK works to promote the needs of EGFR mutation positive lung cancer patients across the UK.
Financial health, per its FY2025 accounts
The accounts state that total receipts for the year were £88,938, with a general surplus of £13,712 added to reserves. The charity holds £24,502 in bank and £70,108 in fixed deposits, while restricted funds of £18,212 are held for a specific project. The trustees report that the charity does not employ staff and has low fixed costs.
What the accounts disclose
“88% came from fundraising and an additional £ 19,169 from Gift Aid”
Trustees
- Nicola Cowlandchair
- Charlotte Judyth Maxwell
- Dr Virginia Mary Harrison
- Elizabeth Lucy Baker
- Ismet Jabeen Sadiq-Shirley
- Soumitra Bose Treasurer
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £89k | £57k |
| 31/03/2024 | £59k | £51k |
| 31/03/2023 | £23k | £10k |
| 31/03/2022 | £38k | £1k |
| 31/03/2021 | £3k | £0 |
Common questions
Is EGFR Positive Lung Cancer UK financially healthy?
Per its FY2025 accounts: The accounts state that total receipts for the year were £88,938, with a general surplus of £13,712 added to reserves. The charity holds £24,502 in bank and £70,108 in fixed deposits, while restricted funds of £18,212 are held for a specific project. The trustees report that the charity does not employ staff and has low fixed costs.